Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
cytomegalovirus immune globulin, intravenous
Known as:
CMVIG
National Institutes of Health
Create Alert
Related topics
Related topics
1 relation
Broader (1)
cytomegalovirus immune globulin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The impact of CMV prevention on long‐term recipient and graft survival in heart transplant recipients: analysis of the Scientific Registry of Transplant Recipients (SRTR) database
David R. Snydman
,
Kristin D. Kistler
,
P. Ulsh
,
Garrett E. Bergman
,
J. Vensak
,
J. Morris
Clinical transplantation
2011
Corpus ID: 6938735
Snydman DR, Kistler KD, Ulsh P, Bergman GE, Vensak J, Morris J. The impact of CMV prevention on long‐term recipient and graft…
Expand
Highly Cited
2008
Highly Cited
2008
CMV‐hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta‐analysis
N. Bonaros
,
B. Mayer
,
T. Schachner
,
G. Laufer
,
A. Kocher
Clinical transplantation
2008
Corpus ID: 20296245
Abstract. Objective: The goal of this meta‐analysis was to investigate the impact of cytomegalovirus hyperimmune globulin…
Expand
Highly Cited
2006
Highly Cited
2006
Acute Rejection and Cardiac Allograft Vascular Disease Is Reduced by Suppression of Subclinical Cytomegalovirus Infection
L. Potena
,
C. Holweg
,
+8 authors
H. Valantine
Transplantation
2006
Corpus ID: 529978
Background. Anticytomegalovirus (CMV) prophylaxis prevents the acute disease but its impact on subclinical infection and…
Expand
Highly Cited
2001
Highly Cited
2001
IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATION: A Comparative Study of Combined Prophylaxis with CMV Hyperimmune Globulin Plus Ganciclovir Versus…
H. Valantine
,
H. Luikart
,
+6 authors
B. Reitz
Transplantation
2001
Corpus ID: 577105
Background. Cytomegalovirus (CMV) disease was previously shown to be unaltered by a 28-day course of ganciclovir compared with…
Expand
Review
2000
Review
2000
Management of cytomegalovirus infection after liver transplantation
P. Sampathkumar
,
C. Paya
Liver transplantation : official publication of…
2000
Corpus ID: 14745399
Abstract Cyromegalovirus (CMV) is a ubiquitous herpesvirus that, together with human herpesvirus type 6 (HHV- 6) and HHV- 7…
Expand
Highly Cited
1997
Highly Cited
1997
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam…
M. George
,
D. Snydman
,
+4 authors
R. Rubin
The American journal of medicine
1997
Corpus ID: 12983584
PURPOSE To assess impact of cytomegalovirus (CMV) donor-recipient serostatus, infection, or disease on development of invasive…
Expand
Highly Cited
1997
Highly Cited
1997
Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
M. Falagas
,
D. Snydman
,
+4 authors
R. Rohrer
Clinical transplantation
1997
Corpus ID: 22760134
Cytomegalovirus (CMV) causes considerable morbidity and mortality in orthotopic liver transplant (OLT) recipients. Several…
Expand
1995
1995
Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates
D. Snydman
,
B. Werner
,
+12 authors
G. Grady
The Pediatric infectious disease journal
1995
Corpus ID: 27666803
We undertook a randomized, placebo‐controlled, double blind trial of cytomegalovirus (CMV) immunoglobulin (CMVIG) for prevention…
Expand
1993
1993
Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study Group.
M. George
,
D. Snydman
,
+6 authors
W. Lewis
Transplantation proceedings
1993
Corpus ID: 41898930
Review
1993
Review
1993
New developments in cytomegalovirus prevention and management.
D. Snydman
,
R. H. Rubin
,
B. Werner
American journal of kidney diseases : the…
1993
Corpus ID: 25903219
The use of CMVIG, approved in 1990 for prophylactic administration in seronegative recipients of kidneys from seropositive donors…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE